ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $238,096 | -70.4% | 51,760 | -58.4% | 0.00% | -50.0% |
| Q2 2023 | $803,546 | -32.7% | 124,388 | -21.5% | 0.00% | -60.0% |
| Q1 2023 | $1,194,540 | -40.3% | 158,427 | -19.8% | 0.01% | -37.5% |
| Q4 2022 | $2,001,404 | +314.4% | 197,572 | +304.9% | 0.01% | +300.0% |
| Q3 2022 | $483,000 | -63.5% | 48,793 | -60.8% | 0.00% | -71.4% |
| Q2 2022 | $1,324,000 | -27.3% | 124,363 | -33.4% | 0.01% | -12.5% |
| Q1 2022 | $1,821,000 | +58.6% | 186,809 | +132.7% | 0.01% | +166.7% |
| Q4 2021 | $1,148,000 | +1.3% | 80,281 | +42.0% | 0.00% | 0.0% |
| Q3 2021 | $1,133,000 | +120.4% | 56,535 | +142.2% | 0.00% | +50.0% |
| Q2 2021 | $514,000 | -3.4% | 23,344 | +49.1% | 0.00% | -33.3% |
| Q1 2021 | $532,000 | – | 15,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |